(2026). Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancer. Clinical Proteomics.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Targeted Proteomics for the Detection of Androgen Receptor Variants in Preclinical Models of Castration-resistant Prostate Cancer."
Clinical Proteomics 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Targeted Proteomics for the Detection of Androgen Receptor Variants in Preclinical Models of Castration-resistant Prostate Cancer."
Clinical Proteomics, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.